Receptor-structured modelling of EGFR-driven tumor initiation: from spatially resolved cell-based simulations to reduced population dynamics
Abstract
Alterations in epidermal growth factor receptor (EGFR) dynamics can influence tumor initiation by changing receptor abundance, ligand-dependent activation, and downstream proliferative signaling. Mathematically linking these receptor-scale processes to population-level tumor growth remains challenging because they couple molecular, cellular, and tissue-scale dynamics. Here, we develop multiscale models that explicitly captures receptor-ligand dynamics. We analyze the dynamics of a refined version of a 3D stochastic multicellular model with explicit EGFR-EGF interactions to derive a receptor-structured continuum model in which cells are organized by active receptor clusters. This model is further reduced into a population dynamics model that tracks the mean number of active receptors. It captures the main qualitative behaviours of the higher-dimensional models while enabling analytical and numerical characterization of model-derived thresholds for sustained growth. After calibration and comparison with available in vivo tumor-growth data under EGFR overexpression, we use the model hierarchy to quantify how initiation thresholds depend on EGF availability, EGFR abundance, receptor-ligand unbinding, and genetic potential. The models predict that EGFR overexpression, stronger receptor-ligand binding, and more aggressive cell phenotypes each lower the EGF molecular counts required for sustained tumor growth. Overall, the proposed framework provides a flexible mathematical approach for connecting receptor-ligand kinetics with population-level tumor-initiation dynamics.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- EGF signaling in bowel carcinoma cells utilizes higher order architectures of EGFR and HER2
Adam Wollman, Charlotte Fournier, … Mark C Leake·bioRxiv·Jul 11, 2020
- EGF signalling in epithelial carcinoma cells utilizes preformed receptor homoclusters, with larger heteroclusters post activation
Charlotte Fournier, Adam J. M. Wollman, … Mark C. Leake·bioRxiv·Apr 20, 2018
- An integrated mechanistic and data-driven computational model predicts cell responses to high- and low-affinity EGFR ligands
Paul J. Myers, Sung Hyun Lee, Matthew J. Lazzara·bioRxiv·Jun 25, 2023
- Spatially localized ligand binding to receptors affects magnitude and timing of signaling response
Nicholas Duong, Sahar A Kamil, … Aidan I. Brown·bioRxiv·Jun 24, 2026
- Distinct interactions stabilize EGFR dimers and higher-order oligomers in cell membranes
K. C. Mudumbi, E. A. Burns, … M. A. Lemmon·bioRxiv·Apr 10, 2023
- Proliferation and differentiation in intestinal organoids as a balance of ligand-modulated EGFR trafficking
Mario O. Caracci, Sabrina Seidler, … Philippe I. H. Bastiaens·bioRxiv·Apr 2, 2026